New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
07:17 EDTILMN, LIFE, FLDM, PACBLeerink to host a tour
Genomics Lab Tour consists of a tour of the Kansas University Medical Center's Genomics Lab and discusses the demand for DNA sequencing technologies, interest in new products, impact of funding constraints and DNA sequencing in the clinic. Relevant covered companies include Illumina, Life Technologies, Fluidigm and Pacific Biosciences. The tour is in Kansas City, Kansas and starts at 2 pm on March 27.
News For ILMN;LIFE;FLDM;PACB From The Last 14 Days
Check below for free stories on ILMN;LIFE;FLDM;PACB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
08:15 EDTLIFE, ILMNEnzo Biochem announces August 18 as date of Markman hearing in lawsuit
Subscribe for More Information
July 24, 2014
16:12 EDTPACBPacific Biosciences reports Q2 EPS (27c), consensus (28c)
Subscribe for More Information
07:18 EDTILMNIllumina price target raised to $195 from $180 at Leerink
Leerink raised its price target for Illumina shares to $195 citing continued instrument momentum following the company's Q2 results. The firm keeps an Outperform rating on the stock.
July 23, 2014
16:23 EDTILMNIllumina raises FY14 EPS view to $2.26-$2.28 from $2.10-$2.15, consensus $2.17
Subscribe for More Information
16:19 EDTILMNIllumina reports Q2 EPS 57c, consensus 51c
Subscribe for More Information
15:30 EDTILMNNotable companies reporting after market close
Subscribe for More Information
July 21, 2014
06:32 EDTILMNIllumina's NGS selected by Berry Genomics
Subscribe for More Information
July 17, 2014
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:20 EDTILMNIllumina initiated with a Buy at Citigroup
Subscribe for More Information
July 16, 2014
06:31 EDTILMNIllumina acquires Myraqa
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use